| Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... The lancet oncology 10 (1), 35-43, 2009 | 2300 | 2009 |
| Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B P Marcellin, TT Chang, SG Lim, MJ Tong, W Sievert, ML Shiffman, ... New England Journal of Medicine 348 (9), 808-816, 2003 | 2072 | 2003 |
| Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: a retrospective study S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ... Hepatology 45 (3), 579-587, 2007 | 768 | 2007 |
| Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma R Golfieri, E Giampalma, M Renzulli, R Cioni, I Bargellini, C Bartolozzi, ... British journal of cancer 111 (2), 255-264, 2014 | 657 | 2014 |
| Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis F Coccolini, F Catena, M Pisano, F Gheza, S Fagiuoli, S Di Saverio, ... International journal of surgery 18, 196-204, 2015 | 591 | 2015 |
| Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre-and Post-Liver Transplantation Patients ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ... Hepatology 38 (6), 1419-1427, 2003 | 579 | 2003 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 537 | 2018 |
| Gut microbiota in autism and mood disorders F Mangiola, G Ianiro, F Franceschi, S Fagiuoli, G Gasbarrini, A Gasbarrini World journal of gastroenterology 22 (1), 361, 2016 | 507 | 2016 |
| Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features S Fasolato, P Angeli, L Dallagnese, G Maresio, E Zola, E Mazza, ... Hepatology 45 (1), 223-229, 2007 | 457 | 2007 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 410 | 2020 |
| Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma U Cillo, A Vitale, M Bassanello, P Boccagni, A Brolese, G Zanus, P Burra, ... Annals of Surgery 239 (2), 150-159, 2004 | 376 | 2004 |
| Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results E Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ... Liver Transplantation 13 (3), 349-360, 2007 | 349 | 2007 |
| Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study LS Belli, M Berenguer, PA Cortesi, M Strazzabosco, SR Rockenschaub, ... Journal of hepatology 65 (3), 524-531, 2016 | 341 | 2016 |
| Association between reactive oxygen species and disease activity in chronic hepatitis C N De Maria, A Colantonl, S Fagiuoli, GJ Liu, BK Rogers, F Farinati, ... Free Radical Biology and Medicine 21 (3), 291-295, 1996 | 311 | 1996 |
| Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ... The Lancet Oncology 21 (7), 947-956, 2020 | 291 | 2020 |
| Prophylaxis and treatment of hepatitis B in immunocompromised patients A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ... Digestive and Liver Disease 39 (5), 397-408, 2007 | 288 | 2007 |
| Response to interferon α therapy is influenced by the iron content of the liver DH Van Thiel, L Friedlander, S Fagiuoli, HI Wright, W Irish, JS Gavaler Journal of hepatology 20 (3), 410-415, 1994 | 282 | 1994 |
| The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? U Cillo, M Bassanello, A Vitale, FA Grigoletto, P Burra, S Fagiuoli, ... Journal of hepatology 40 (1), 124-131, 2004 | 254 | 2004 |
| Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of … M Pompili, VG Mirante, G Rondinara, LR Fassati, F Piscaglia, S Agnes, ... Liver transplantation 11 (9), 1117-1126, 2005 | 249 | 2005 |
| Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ... Journal of hepatology 66 (3), 552-559, 2017 | 224 | 2017 |
Umberto CilloUnità di Chirurgia Epatobiliare e Trapianto Epatico, Università degli Studi di PadovaVerified email at unipd.it